Related by context. All words. (Click for frequent words.) 69 GDIR 66 lorcaserin hydrochloride 66 Triolex 66 Lorcaserin 65 PRX # 65 BCX# 65 Empatic 65 ISIS # 65 otelixizumab 64 PSN# [002] 64 R#/MEM # 64 teduglutide 63 enzastaurin 63 pramlintide 63 lorcaserin 63 GPR# agonist 63 Phenoptin 63 Nasulin 63 preclinical 63 Panzem 63 davalintide 63 HGS ETR1 62 BAY #-# 62 5 HT2C serotonin 62 GPR# agonists 62 BLOOM DM 62 ELND# 62 AP# [003] 62 tasimelteon 62 mertansine 62 PEG SN# 62 commercialize lorcaserin 62 AEGR 62 PS# [001] 62 JAK inhibitor 62 Mipomersen 61 PEG Interferon lambda 61 PEG PAL 61 Nanobody 61 elotuzumab 61 Bicifadine 61 ALN PCS 61 alvespimycin 61 dimebon 61 OXi# 61 INCB# [002] 61 preclinical studies 61 incyclinide 61 CR# vcMMAE 61 SARMs 61 PDE4 inhibitor 60 nalbuphine ER 60 LY# [003] 60 RGB # 60 MAP# 60 orally bioavailable 60 AZD# 60 NGX# 60 CoFactor 60 pralatrexate 60 EOquin 60 forodesine 60 rNAPc2 60 mapatumumab 60 Lorqess 60 vidofludimus 60 pradefovir 60 TRIOLEX 60 Phase Ib 60 obatoclax 60 perifosine 60 registrational 60 selective androgen receptor modulator 60 Marqibo 60 almorexant 60 CRx 60 MEK inhibitor 60 investigational compound 60 Plicera 60 GALNS 60 HspE7 60 bicifadine 60 MGCD# [001] 60 dacetuzumab 60 TELINTRA 60 AEG# 60 vilazodone 60 mipomersen 60 Chemophase 60 tiapamil 59 Serdaxin 59 adipiplon 59 Zybrestat 59 celgosivir 59 Pimavanserin 59 valopicitabine 59 Targretin 59 MDV# 59 Aurexis 59 XL# XL# 59 CORT # 59 PXD# 59 belinostat 59 Anturol 59 thymalfasin 59 AZILECT R 59 pharmacodynamic effects 59 HGS# 59 oral prodrug 59 TKM ApoB 59 Archexin 59 teplizumab 59 INCB# [001] 59 eltrombopag 59 Panzem R 59 TLK# 59 GLPG# 59 GSK# [002] 59 PRT# 59 investigational drug 59 ELADUR 59 XL# XL# XL# XL# 59 Phase 2a trial 59 partner lorcaserin APD# 59 Tyrima 59 Perifosine 59 TELCYTA 59 EOquin TM 59 Azedra ™ 59 axitinib 59 VA# [002] 59 ICA # 59 talactoferrin 59 Dapagliflozin 59 MAXY G# 59 orally administered 59 Zerenex 59 tezampanel 59 Phase Ib study 59 ganetespib 59 ularitide 59 MAGE A3 ASCI 59 SILENOR 58 TOCOSOL Paclitaxel 58 phase IIb 58 XL# [003] 58 Synavive 58 investigational humanized monoclonal antibody 58 LAF# 58 eprotirome 58 Corlux 58 torsemide ER 58 SILENOR TM 58 Phase 2b clinical 58 pramlintide metreleptin 58 PDX pralatrexate 58 #ME# 58 CA4P 58 Menerba 58 nonclinical studies 58 midstage clinical 58 EndoTAG TM -1 58 phase IIb clinical 58 PSN# [001] 58 phase IIa clinical 58 MGCD# [002] 58 IAP inhibitors 58 RDEA# 58 PLK1 SNALP 58 velafermin 58 SAR# [004] 58 insulin sensitizing 58 cannabinor 58 6R BH4 58 daclizumab 58 glufosfamide 58 SRT# [003] 58 Traficet EN 58 Ostarine 58 MEK inhibitors 58 Phase III clinical 58 HGS ETR2 58 tolerability 58 Capesaris 58 AVN# [001] 58 Actilon 58 Golimumab 58 solanezumab 58 ataluren 58 Technosphere Insulin 58 retigabine 58 pomalidomide 58 APOPTONE 58 alvimopan 58 Chrysalin 58 Symadex 58 ALN TTR 58 HuLuc# 58 Phase 1b trial 58 TBC# 58 urate lowering 58 Sulonex 58 XL# XL# XL# 58 #D#C# 58 squalamine 58 huC# DM4 58 HuMax EGFr 58 5 HT2C receptor 58 metaglidasen 58 rFIXFc 58 investigational hepatitis C 58 Azedra 58 Phase III clinical trials 57 ancrod 57 Jack Lief Arena 57 lomitapide 57 tesofensine 57 CCX# 57 KRN# 57 diabetic neuropathic pain 57 iSONEP 57 visilizumab 57 L BLP# 57 docetaxel Taxotere R 57 HCD# [002] 57 Virulizin R 57 HuMax CD# 57 Contrave# 57 regorafenib 57 VEGF Trap 57 Panzem R NCD 57 Virulizin ® 57 LibiGel ® 57 atacicept 57 veltuzumab 57 muraglitazar 57 linaclotide 57 bremelanotide 57 ThGRF 57 maximally tolerated dose 57 cangrelor 57 Nuvion 57 Phase Ib clinical 57 CINTREDEKIN BESUDOTOX 57 Abiraterone acetate 57 vicriviroc 57 Vilazodone 57 Dalbavancin 57 RhuDex ® 57 Bezielle 57 ocrelizumab 57 Phase #b/#a trial 57 tanespimycin 57 Phase IIb trials 57 Sulonex TM 57 pertuzumab 57 DDP# 57 aflibercept 57 methylnaltrexone 57 AKT inhibitor 57 ALN TTR# 57 INC# 57 LY# [002] 57 PRTX 57 THR beta agonist 57 fenofibric acid 57 lapatinib Tykerb 57 CORLUX 57 neratinib 57 sodium glucose cotransporter 57 deforolimus 57 investigational monoclonal antibody 57 Phase IIb clinical trials 57 Fibrillex TM 57 FTY# 57 ridaforolimus 57 epothilone 57 5 HT2C 57 HCV protease inhibitor 57 Androxal TM 57 bevirimat 57 AVE# 57 DOS# 57 oral salmon calcitonin 57 Squalamine 57 Vitaxin 57 ATL/TV# 57 romazarit 56 Darusentan 56 Nanobody ® 56 Trizytek 56 Phase 2b study 56 QLT# 56 Qnexa 56 custirsen 56 Troxatyl 56 Asentar 56 lintuzumab 56 OvaRex R 56 BiTE antibody 56 dirucotide 56 elagolix 56 JAK3 inhibitor 56 Cloretazine R VNP#M 56 ZOLINZA 56 AzaSite Plus 56 lumiliximab 56 Locteron 56 ALN RSV# 56 JAK2 inhibitor 56 opioid bowel dysfunction 56 Contrave 56 refractory gout 56 Insegia 56 darapladib 56 IV APAP 56 SNRI 56 aclidinium bromide 56 5 HT2A receptor 56 tolerability profiles 56 sitagliptin 56 Phase 2a 56 atrasentan 56 prostone 56 Retigabine 56 Satraplatin 56 Phase 2a clinical 56 ENMD # 56 Cleviprex TM clevidipine 56 EP #R 56 ATL# [001] 56 GSK # 56 Apixaban 56 lorcaserin NDA 56 class mGluR5 inhibitor 56 tramiprosate Alzhemed TM 56 Phase IIb clinical 56 PROMACTA 56 ramelteon 56 reslizumab 56 Phenserine 56 TREANDA 56 Iloperidone 56 CK # 56 Amigal 56 MLN# 56 iloperidone 56 telbivudine 56 SERMs 56 IMGN# 56 YONDELIS 56 selective modulator 56 synthetic retinoid 56 taribavirin 56 BEMA Buprenorphine 56 clinical trials 56 Gabapentin GR 56 rindopepimut 56 GAMMAGARD 56 LEP ETU 56 ApoB SNALP 56 HCV protease inhibitors 56 systemic RNAi therapeutic 56 UPLYSO 56 SCH # 56 isoform selective 56 Zoraxel 56 mGluR2 NAM 56 RELOVAIR ™ 56 NUVIGIL 56 Phase #b/#a 56 Azixa 56 SAR# [002] 56 thiazolidinedione 56 NVA# 56 aclidinium 56 liprotamase 56 Exelixis compounds 56 IMC A# 56 Nexavar ® 56 IDX# 56 insulin sensitizers 56 tesmilifene 56 Lixivaptan 56 XP# XP# 56 Phase 1b 56 bardoxolone 56 Phase IIa clinical trials 56 sargramostim 56 E2F Decoy 56 eniluracil 56 Aurora kinase inhibitor 56 ozarelix 56 MAXY VII 56 voreloxin 56 antidiabetic 56 Gaboxadol 56 CIMZIA TM 56 PI3K/Akt pathway inhibitor 56 Synavive ™ 56 Syncria 56 CD NP 56 brivaracetam 56 anticancer compound 56 Aurora kinase 56 omecamtiv mecarbil 56 Cetrorelix 56 ANAVEX #-# [003] 56 CINOD 56 Genz # 56 TG# [003] 56 stated Jack Lief 56 phase Ib 56 febuxostat 56 Allovectin 7 R 56 Phase III trials 56 DPP4 56 riociguat 56 safinamide 56 Saxagliptin 56 ATL# [002] 56 TACI Ig 56 Fodosine 56 OMP #M# 56 oral formulation 56 ALN HPN 56 entinostat 56 ALVESCO HFA 56 lesinurad 56 schizophrenia CIAS 55 peripherally acting 55 Tasimelteon 55 Zolinza 55 teriflunomide 55 INS# [001] 55 ALTU 55 XmAb# 55 FOLOTYN ® 55 ProSavin 55 Trofex 55 SinuNase 55 Phase IIa clinical 55 picoplatin 55 mecamylamine 55 registrational trial 55 midstage clinical trials 55 AFREZZA 55 sorafenib tablets 55 Topical Interferon Alpha 2b 55 XL# anticancer compounds 55 CD# CEA 55 EndoTAGTM 1 55 ZYBRESTAT 55 Phase IIa trial 55 pharmacodynamic 55 danoprevir 55 TNF Tumor Necrosis Factor 55 ALKS 55 betrixaban 55 Veronate 55 JANUVIA 55 investigational pan BCR 55 UVIDEM 55 sunitinib malate 55 Silodosin 55 MEK inhibitor RDEA# 55 glucokinase activator 55 bosutinib 55 trospium 55 motesanib 55 Xanafide 55 Ixempra 55 regadenoson 55 orally administered inhibitor 55 ALK inhibitor 55 CYT# 55 Tarvacin TM 55 Hsp# inhibitors 55 LymphoStat B 55 ONCONASE R 55 Desmoteplase 55 Tekamlo 55 SNALP technology 55 Neurodex 55 viral kinetic 55 Eltrombopag 55 targeted radiotherapeutic 55 posaconazole 55 velafermin belinostat 55 Omigard 55 sodium thiosulfate STS 55 placebo controlled Phase 55 iroxanadine 55 Onbrez Breezhaler 55 AOD# [002] 55 efficacy tolerability 55 Ramelteon 55 GRN#L 55 Factor VIIa 55 Tesetaxel 55 Onco TCS 55 Bortezomib 55 ISTODAX 55 BZL# 55 ruxolitinib 55 GAP #B# 55 MYDICAR 55 CTAP# Capsules 55 Dacogen injection 55 IMC #B 55 sorafenib Nexavar 55 hypoxia selective 55 clinical pharmacology studies 55 Acapodene 55 BEMA TM Fentanyl 55 Zalbin 55 Posiphen 55 RSD# oral 55 PREOS 55 dextofisopam 55 satraplatin 55 Avanafil 55 favorable pharmacokinetic profile 55 Exelixis XL# 55 ASONEP 55 investigational compounds 55 Phase IIb 55 oral antiviral 55 Omnitarg 55 Urocortin 2 55 metformin sulfonylurea 55 lorvotuzumab mertansine 55 OvaRex ® MAb 55 beta interferons 55 Androxal ® 55 ORENCIA R 55 pharmacodynamic properties 55 favorable pharmacokinetic 55 REOLYSIN ® 55 Androxal 55 iniparib 55 Seliciclib 55 Azedra TM 55 RG# [001] 55 AEZS 55 Vaprisol 55 tofacitinib 55 DR Cysteamine 55 GED aPC 55 CYT# potent vascular disrupting 55 proteasome inhibitor 55 novel anticancer 55 ADX# 55 BNC# 55 Safinamide 55 Clonicel 55 bifeprunox 55 Leukine ® 55 Allovectin 7 ® 55 PD LID 55 vosaroxin 55 Onconase 55 TRV# [001] 55 ofatumumab 55 lixivaptan 55 Icatibant 55 telcagepant 55 pegloticase 55 Entereg R 55 EVIZON TM squalamine lactate 55 torezolid phosphate 55 RIGScan CR 55 protein kinase inhibitor 55 TYZEKA 55 Personalized Immunotherapy 55 Pruvel 55 oral deforolimus 55 CXB# 55 AERx iDMS 55 ponatinib 55 Ramoplanin 55 Enzastaurin 55 liposomal formulation 55 volociximab 55 ELACYT 55 JAK1 55 tolevamer 55 ARRY 55 prucalopride 55 PEG INTRON 55 Darapladib 55 cilengitide 55 urocortin 2 55 pharmacokinetics PK 55 Belinostat 55 Zelapar 55 opioid induced bowel dysfunction 55 antithrombotic 55 Solazed 55 DAVANAT R 55 virus HCV protease inhibitor 55 sapacitabine 55 MBP# [001] 55 pivotal Phase III 55 perampanel 54 ibudilast 54 Naproxcinod 54 evaluating tivozanib 54 NU# [001] 54 TAFA# 54 Stedivaze 54 brentuximab vedotin 54 Alzhemed TM 54 trastuzumab DM1 T DM1 54 cediranib 54 Surfaxin LS 54 uric acid lowering 54 Bronchitol 54 OX1 54 L DOS# 54 Carfilzomib 54 Viramidine 54 Tolerx 54 Muraglitazar 54 interferon gamma 1b 54 Oral NKTR 54 Daclizumab 54 trodusquemine 54 FavId 54 enoximone 54 bevasiranib 54 Glypromate 54 JAK3 54 Chief Executive Jack Lief 54 Prosaptide 54 antisense drug 54 Amplimexon 54 DPX Survivac 54 Phase 2b trial 54 imetelstat 54 Huntexil 54 Denufosol 54 Ocrelizumab 54 ascending dose 54 Atrasentan 54 DermaVir Patch 54 Imprime PGG 54 Aerosurf 54 multitargeted 54 initiate Phase 1b 54 tasocitinib 54 nab paclitaxel 54 Aflibercept 54 pitavastatin 54 EGS# 54 Puricase 54 abiraterone acetate 54 Pyridorin 54 COMT inhibitors 54 preclinical pharmacokinetic 54 Phase Ib clinical trials 54 confirmatory Phase III 54 Shigamabs ® 54 sirtuin modulators 54 SPP# [001] 54 MYDICAR ® 54 anidulafungin 54 pharmacodynamic markers 54 tecarfarin 54 Sandostatin LAR 54 Anturol ® 54 RLY# 54 Diamyd ® 54 investigational oral anticoagulant 54 faropenem medoxomil 54 NP2 Enkephalin 54 alfimeprase 54 Guanilib 54 Velcade bortezomib 54 preclinically 54 PF # [001] 54 HCV nucleoside polymerase inhibitors 54 Phase 1b clinical 54 LibiGel Phase III 54 alkylating agent 54 AMPAKINE R 54 denufosol 54 Kuvan 54 R sorafenib tablets 54 Leukine 54 Tarceva TM 54 Cardio Vascu Grow 54 refractory APL 54 Laquinimod 54 ASA# 54 erlotinib Tarceva ® 54 OHR/AVR# 54 cetrorelix 54 OncoVEX GM CSF 54 canagliflozin 54 disease modifying 54 Relivar 54 VIAtab TM 54 Hyphanox 54 Elagolix 54 treprostinil 54 INCB# [003] 54 Canvaxin 54 Phase IIIb clinical 54 AQ4N 54 chemotherapy induced neutropenia 54 fostamatinib 54 anti leukemic 54 tipifarnib 54 KNS # 54 GATTEX 54 DexaSite 54 IL# PE#QQR 54 brostallicin 54 Cethrin 54 Aganocide 54 HCV SPRINT 54 HuMax CD4 54 postoperative ileus POI 54 TroVax 54 prGCD 54 P#X# antagonist 54 blinatumomab 54 TriRima 54 Aclidinium 54 CDK inhibitor 54 immunomodulatory 54 phase IIb trial 54 sodium glucose transporter 54 LEVADEX 54 Rescula 54 Glufosfamide 54 GRN# 54 subcutaneously administered 54 Viprinex 54 Phase III Pivotal 54 Cethromycin 54 Novolimus 54 novel VDA molecule 54 Lu AA# 54 Onalta ™ 54 PDE4 inhibitors 54 Sudhir Agrawal D.Phil 54 bendamustine 54 Ophena TM 54 2 methoxyestradiol 54 ALN VSP 54 mGluR5 NAM 54 QVA# 54 Phase III 54 NN# [001] 54 tezampanel NGX# 54 Phase Ib II 54 MB# [004] 54 Afatinib 54 ZYBRESTAT fosbretabulin 54 PHX# 54 Budesonide MMX 54 integrase inhibitor 54 Teriflunomide 54 insulin sensitizer 54 bortezomib Velcade 54 orally dosed 54 Rasagiline 54 non nucleoside HCV 54 NKTR 54 gallium containing 54 bafetinib 54 antiarrhythmic drug 54 adalimumab Humira 54 RE SURGE 54 Allovectin 7 54 Valdoxan 54 eritoran 54 Phase IIB 54 figitumumab CP 54 PEGylated 54 Romidepsin 54 Sym# 54 rxRNA 54 Vernakalant 54 Rebif ® 54 REMOXY ® 54 limiting toxicity 54 abiraterone 54 Gemzar ® 54 USL# 54 goserelin 54 highly selective inhibitor 54 PCK# 54 targeting CD# 54 avanafil 54 insulin detemir 54 IAP inhibitor 54 Nexavar sorafenib 54 APPRAISE 54 gefitinib Iressa 54 investigational oral 54 oral anticancer 54 preclinical compounds 54 Rezular 54 Ridaforolimus 54 PYY #-# 54 MKC# MT 54 pharmacokinetic PK profile 54 Fx #A 54 HQK 54 Sanctura XR 54 Milnacipran 54 Neo Kidney Augment 54 PRE SURGE 54 pharmacodynamic PD 54 PYY3 54 Metabasis 54 Phase IIa trials 54 angioedema indications 54 dose escalation 54 Amrubicin 54 bapineuzumab 54 GPCR targets 54 Zemiva TM 54 selective androgen receptor modulators 54 Telintra 54 Aptivus ® 54 Dextofisopam 54 aurora kinase 54 generation purine nucleoside 54 CORLUX CORT # 54 odanacatib 54 QNEXA 54 C1 INH 54 Aganocide ® 54 samalizumab 54 tremelimumab 54 ANA# 54 octreotide acetate 53 Phase 2b 53 Alocrest 53 Hsp# inhibitor 53 optimal dosing 53 afatinib 53 baminercept 53 indiplon 53 adenosine A2A 53 Blinatumomab 53 CIMZIA ™ 53 Immunotherapeutic 53 REG1 53 gaboxadol 53 lixisenatide 53 Trofex TM 53 JZP 6 53 Stimuvax R 53 oral ridaforolimus 53 CYC# 53 leukotriene receptor antagonists 53 NOX E# 53 senicapoc 53 telomerase therapeutic 53 immune modulating 53 FM VP4 53 LNP formulations 53 resolvins 53 SinuNase ™ 53 Preclinical studies suggest 53 Starlix 53 Vicriviroc 53 immunomodulator 53 IPL# 53 systemically administered 53 DAVANAT 53 Prestara 53 epothilones 53 TMC# [002] 53 ADVEXIN clinical 53 GSK# [001] 53 Genasense ® 53 IL# PE 53 Tezampanel 53 panitumumab Vectibix 53 phase IIb study 53 Spiegelmer ® 53 VEGF inhibitors 53 ACADIA 53 mixed dyslipidemia 53 Firazyr 53 acyclovir Lauriad R 53 Ereska 53 viral kinetics 53 indiplon capsules 53 carfilzomib 53 Omacetaxine mepesuccinate 53 Atu# 53 pharmacokinetic studies 53 ACZ# 53 ocular formulation 53 RhuDex 53 vascular disrupting agents 53 IMiDs R 53 Cloretazine R 53 palifosfamide Zymafos TM 53 olaparib 53 albinterferon alfa 2b 53 iclaprim 53 Theratope 53 antiresorptive 53 docetaxel chemotherapy 53 multicenter Phase II 53 Ambrisentan 53 Xinlay 53 pharmacological chaperone 53 Voreloxin 53 vascular disrupting agent 53 Cerashield 53 Tolvaptan 53 tocilizumab 53 CD# antibody [001] 53 DEB# 53 pafuramidine 53 EVIZON 53 DXL# 53 sitaxsentan 53 zonisamide SR 53 Panzem NCD 53 Anavex #-# 53 Acetavance 53 antihypertensive agents 53 tamibarotene 53 alemtuzumab Campath 53 antisense drugs 53 Lung Rx 53 outlicensing 53 Emisphere 53 faropenem 53 LymphoStat B TM 53 OMAPRO 53 plasma pharmacokinetics 53 NEUVENGE 53 THALOMID 53 SIRT1 activators 53 Cinquil 53 Nicole Onetto MD 53 mGluR5 negative 53 eprodisate Fibrillex TM 53 nucleoside analogues 53 DU #b 53 TPI ASM8 53 glucagon receptor 53 Rasilez Tekturna 53 MOZOBIL 53 telaprevir VX 53 Indaflex TM 53 infliximab Remicade 53 NV1FGF 53 trastuzumab DM1 53 pan HDAC inhibitor 53 rHuPH# 53 orBec 53 VEGF inhibitor 53 Cintredekin Besudotox 53 dexanabinol 53 CINQUIL 53 RNAi therapeutic targeting PCSK9 53 indibulin 53 BYDUREON 53 PSMA ADC 53 HCV protease 53 R#/MEM 53 Specifid 53 intranasal formulation 53 ALVESCO R 53 cobiprostone 53 vorinostat 53 cathepsin K inhibitor 53 PNP inhibitor 53 ARIKACE ™ 53 oxidative stress inducer 53 PrevOnco ™ 53 Proellex TM 53 cetuximab Erbitux 53 FOLOTYN 53 INKP 53 figitumumab 53 angiogenesis inhibitors 53 Thelin TM 53 histone deacetylase inhibitor 53 Tykerb 53 Hedgehog signaling pathway 53 oral cladribine 53 tgAAC# 53 receptor agonists 53 antagomirs 53 NATRECOR R 53 RezularTM